Recombinant Semliki Forest virus particles encoding the prME or NS1 proteins of louping ill virus protect mice from lethal challenge

Journal of General Virology

Volumn 80, Issue 5, 1999, Pages 1189-1198

  Fleeton, Marina N ^a   Sheahan, Brian J ^b   Gould, Ernest A ^c   Atkins, Gregory J ^d   Liljeström, Peter ^a,e  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY COLLEGE DUBLIN   (Ireland)

^c CENTRE FOR ECOLOGY AND HYDROLOGY   (United Kingdom)

^d TRINITY COLLEGE DUBLIN   (Ireland)

^e SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G2A; VIRUS ANTIBODY; VIRUS RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRAIN BHK; HELPER CELL; IMMUNIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEMLIKI FOREST ALPHAVIRUS; TICK BORNE ENCEPHALITIS FLAVIVIRUS; VIRUS IMMUNITY; VIRUS PARTICLE; VIRUS RECOMBINANT;

EID: 0032926034     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-80-5-1189     Document Type: Article

References (55)

1. Allison, S. L., Schalich, J., Stiasny, K., Mandl, C. W., Kunz, C. & Heinz, F. X. (1995a). Oligomeric rearrangement of tick-borne encephalitis virus envelope proteins induced by an acidic pH. Journal of Virology 69, 695-700.
2. Allison, S. L., Stadler, K., Mandl, C. W., Kunz, C. & Heinz, F. X. (1995b). Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form. Journal of Virology 69, 5816-5820.
3. Berglund, P., Sjöberg, M., Garoff, H., Atkins, G. J., Sheahan, B. J. & Liljeström, P. (1993). Semliki Forest virus expression system: production of conditionally infectious recombinant particles. Bio/Technology 11, 916-920.
4. Berglund, P., Smerdou, C. S., Fleeton, M. N., Tubulekas, I. & Liljeström, P. (1998). Enhancing immune responses using suicidal DNA vaccines. Nature Biotechnology 16, 562-565.
5. Berglund, P., Fleeton, M. N., Smerdou, C. S. & Liljeström, P. (1999). Immunization with recombinant Semliki Forest virus induces protection against influenza virus challenge in mice. Vaccine 17, 508-518.
6. Chambers, T. J., Hahn, C. S., Galler, R. & Rice, C. M. (1990). Flavivirus genome organization, expression, and replication. Annual Review of Microbiology 44, 649-688.
7. Collins, C. H. (1988). Laboratory-Acquired Infections. London: Butterworth.
8. Colombage, G., Hall, R., Pavy, M. & Lobigs, M. (1998). DNA-based and alphavirus-vectored immunisation with prME and E proteins elicits long-lived and protective immunity against the flavivirus, Murray Valley encephalitis virus. Virology 250, 151-163.
9. Davidson, M. M., Williams, H. & Macleod, J. A. J. (1991). Louping ill in man: a forgotten disease. Journal of Infection 23, 241-249.
10. Fan, W. F. & Mason, P. W. (1990). Membrane association and secretion of the Japanese encephalitis virus NS1 protein from cells expressing NS1 cDNA. Virology 177, 470-476.
11. Gao, G. F., Hussain, M. H., Reid, H. W. & Gould, E. A. (1994). Identification of naturally occurring monoclonal antibody escape variants of louping ill virus. Journal of General Virology 75, 609-614.
12. Glasgow, G. M., McGee, M. M., Tarbatt, C. J., Mooney, D. A., Sheahan, B. J. & Atkins, G. J. (1998). The Semliki Forest virus vector induces p53-independent apoptosis. Journal of General Virology 79, 2405-2410.
13. Gould, E. A., Buckley, A., Barrett, A. D. T. & Cammack, N. (1986). Neutralizing (54K) and non-neutralizing (54K and 48K) monoclonal antibodies against structural and non-structural yellow fever virus proteins confer immunity in mice. Journal of General Virology 67, 591-595.
14. + T-lymphocyte responses in a recipient of an experimental live-attenuated dengue virus type 1 vaccine: bulk culture proliferation, clonal analysis, and precursor frequency determination. Journal of Virology 67, 5962-5967.
15. + cytotoxic T lymphocyte clones. Virology 234, 383-386.
16. Guirakhoo, F., Heinz, F. X., Mandl, C. W., Holzmann, H. & Kunz, C. (1991). Fusion activity of flaviviruses: comparison of mature and immature (prM-containing) tick-borne encephalitis virions. Journal of General Virology 72, 1323-1329.
17. Halstead, S. B. (1988). Pathogenesis of dengue: challenges to molecular biology. Science 239, 476-481.
18. Heinz, F. X., Stiasny, K., Püschner-Auer, G., Holzmann, H., Allison, S. L., Mandl, C. W. & Kunz, C. (1994). Structural changes and functional control of the tick-borne encephalitis virus glycoprotein E by the heterodimeric association with protein prM. Virology 198, 109-117.
19. Heinz, F. X., Allison, S. L., Stiasny, K., Schalich, J., Holzmann, H., Mandl, C. W. & Kunz, C. (1995). Recombinant and virion-derived soluble and particulate immunogens for vaccination against tick-borne encephalitis. Vaccine 13, 1636-1642.
20. Jacobs, S. C., Stephenson, J. R. & Wilkinson, G. W. G. (1992). High level expression of the tick-borne encephalitis virus NS1 protein by using an adenovirus-based vector: protection elicited in a murine model. Journal of Virology 66, 2086-2095.
21. Jiang, W. R., Lowe, A., Higgs, S., Reid, H. & Gould, E. A. (1993). Single amino acid codon changes detected in louping ill virus antibody-resistant mutants with reduced neurovirulence. Journal of General Virology 74, 931-935.
22. Kanesa-thasan, N., Putnak, R. & Hoke, C. H., Jr (1997). New and improved vaccines for Dengue, Japanese encephalitis, and yellow fever viruses. In New Generation Vaccines, 2nd edn, vol. 1, pp. 587-606. Edited by M. Levine, G. Woodrow, J. Kaper & G. Cobon. New York: Marcel Dekker.
23. Konishi, E., Pincus, S., Paoletti, E., Shope, R. E., Burrage, T. & Mason, P. W. (1992). Mice immunized with a subviral particle containing the Japanese encephalitis virus prM/M and E proteins are protected from lethal JEV infection. Virology 188, 714-720.
24. Koprowski, H. & Weiner, D. B. (1998). DNA vaccination/genetic vaccination. Current Topics in Microbiology and Immunology 226, V-XIII.
25. Kreil, T. R. & Eibl, M. M. (1997). Pre-and postexposure protection by passive immunoglobulin but no enhancement of infection with a flavivirus in a mouse model. Journal of Virology 71, 2921-2927.
26. Kreil, T. R., Maier, E., Fraiss, S. & Eibl, M. M. (1998). Neutralizing antibodies protect against lethal flavivirus challenge but allow for the development of active humoral immunity to a nonstructural virus protein. Journal of Virology 72, 3076-3081.
27. Lai, C. J., Zhao, B. T., Hori, H. & Bray, M. (1991). Infectious RNA transcribed from stably cloned full-length cDNA of dengue type 4 virus. Proceedings of the National Academy of Sciences, USA 88, 5139-5143.
28. Liljeström, P. & Garoff, H. (1991). A new generation of animal cell expression vectors based on the Semliki Forest virus replicon. Bio/ Technology 9, 1356-1361.
29. Lin, Y. L., Chen, L. K., Liao, C. L., Yeh, C. T., Ma, S. H., Chen, J. L., Huang, Y. L., Chen, S. S. & Chiang, H. Y. (1998). DNA immunization with Japanese encephalitis virus nonstructural protein NS1 elicits protective immunity in mice. Journal of Virology 72, 191-200.
30. Lindenbach, B. D. & Rice, C. M. (1997). trans-Complementation of yellow fever virus NS1 reveals a role in early RNA replication. Journal of Virology 71, 9608-9617.
31. McGuire, K., Holmes, E. C., Gao, G. F., Reid, H. W. & Gould, E. A. (1998). Tracing the origins of louping ill virus by molecular phylogenetic analysis. Journal of General Virology 79, 981-988.
32. Mackenzie, J. M., Jones, M. K. & Young, P. R. (1996). Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication. Virology 220, 232-240.
33. Mandl, C. W., Heinz, F. X., Stöckl, E. & Kunz, C. (1989). Genome sequence of tick-borne encephalitis virus (Western subtype) and comparative analysis of nonstructural proteins with other flaviviruses. Virology 173, 291-301.
34. Mandl, C. W., Ecker, M., Holzmann, H., Kunz, C. & Heinz, F. X. (1997). Infectious cDNA clones of tick-borne encephalitis virus European subtype prototypic strain Neudoerfl and high virulence strain Hypr. Journal of General Virology 78, 1049-1057.
35. Mason, P. W. (1989). Maturation of Japanese encephalitis virus glycoproteins produced by infected mammalian and mosquito cells. Virology 169, 354-364.
36. Monath, T. P. & Heinz, F. X. (1996). Flaviviruses. In Fields Virology, 3rd edn, pp. 961-1034. Edited by B. N. Fields, D. M. Knipe & P. M. Howley. Philadelphia: Lippincott-Raven.
37. Moss, B. (1996). Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety. Proceedings of the National Academy of Sciences, USA 93, 11341-11348.
38. Muylaert, I. R., Chambers, T. J., Galler, R. & Rice, C. M. (1996). Mutagenesis of the N-linked glycosylation sites of the yellow fever virus NS1 protein: effects on virus replication and mouse neurovirulence. Virology 222, 159-168.
39. Muylaert, I. R., Galler, R. & Rice, C. M. (1997). Genetic analysis of the yellow fever virus NS1 protein: identification of a temperature-sensitive mutation which blocks RNA accumulation. Journal of Virology 71, 291-298.
40. Paoletti, E. (1996). Applications of pox virus vectors to vaccination: an update. Proceedings of the National Academy of Sciences, USA 93, 11349-11353.
41. Pugachev, K. V., Mason, P. W. & Frey, T. K. (1995 a). Sindbis vectors suppress secretion of subviral particles of Japanese encephalitis virus from mammalian cells infected with SIN-JEV recombinants. Virology 209, 155-166.
42. Pugachev, K. V., Mason, P. W., Shope, R. E. & Frey, T. K. (1995 b). Double-subgenomic Sindbis virus recombinants expressing immunogenic proteins of Japanese encephalitis virus induce significant protection in mice against lethal JEV infection. Virology 212, 587-594.
43. Rey, F. A., Heinz, F. X., Mandl, C., Kunz, C. & Harrison, S. C. (1995). The envelope glycoprotein from tick-borne encephalitis virus at 2 Ȧ resolution. Nature 375, 291-298.
44. Rice, C. M. (1996). Flaviviridae: the viruses and their replication. In Fields Virology, 3rd edn, pp. 931-959. Edited by B. N. Fields, D. M. Knipe & P. M. Howley. Philadelphia: Lippincott-Raven.
45. Rothman, A. L., Kurane, I., Zhang, Y. M., Lai, C. J. & Ennis, F. A. (1989). Dengue virus-specific murine T-lymphocyte proliferation: serotype specificity and response to recombinant viral proteins. Journal of Virology 63, 2486-2491.
46. Salminen, A., Wahlberg, J. M., Lobigs, M., Liljeström, P. & Garoff, H. (1992). Membrane fusion process of Semliki Forest virus. II: Cleavage-dependent reorganization of the spike protein complex controls virus entry. Journal of Cell Biology 116, 349-357.
47. Schalich, J., Allison, S. L., Stiasny, K., Mandl, C. W., Kunz, C. & Heinz, F. X. (1996). Recombinant subviral particles from tick-borne encephalitis virus are fusogenic and provide a model system for studying flavivirus envelope glycoprotein functions. Journal of Virology 70, 4549-4557.
48. Schlesinger, J. J., Brandriss, M. W., Cropp, C. B. & Monath, T. P. (1986). Protection against yellow fever in monkeys by immunization with yellow fever virus nonstructural protein NS1. Journal of Virology 60, 1153-1155.
49. Schlesinger, J. J., Brandriss, M. W., Putnak, J. R. & Walsh, E. E. (1990). Cell surface expression of yellow fever virus non-structural glycoprotein NS1: consequences of interaction with antibody. Journal of General Virology 71, 593-599.
50. Schlesinger, J. J., Foltzer, M. & Chapman, S. (1993). The Fc portion of antibody to yellow fever virus NS1 is a determinant of protection against YF encephalitis in mice. Virology 192, 132-141.
51. Schmaljohn, C., Vanderzanden, L., Bray, M., Custer, D., Meyer, B., Li, D., Rossi, C., Fuller, D., Fuller, J., Haynes, J. & Huggins, J. (1997). Naked DNA vaccines expressing the prM and E genes of Russian spring summer encephalitis virus and Central European encephalitis virus protect mice from homologous and heterologous challenge. Journal of Virology 71, 9563-9569.
52. Shiu, S. Y. W., Reid, H. W. & Gould, E. A. (1992). Louping ill virus envelope protein expressed by recombinant baculovirus and vaccinia virus fails to stimulate protective immunity. Virus Research 26, 213-229.
53. Sumiyoshi, H., Hoke, C. H. & Trent, D. W. (1992). Infectious Japanese encephalitis virus RNA can be synthesized from in vitro-ligated cDNA templates. Journal of Virology 66, 5425-5431.
54. Zhou, X., Berglund, P., Rhodes, G., Parker, S. E., Jondal, M. & Liljeström, P. (1994). Self-replicating Semliki Forest virus RNA as recombinant vaccine. Vaccine 12, 1510-1514.
55. Zhou, X., Berglund, P., Zhao, H., Liljeström, P. & Jondal, M. (1995). Generation of cytotoxic and humoral immune responses by non-replicative recombinant Semliki Forest virus. Proceedings of the National Academy of Sciences, USA 92, 3009-3013.